Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03212469
Title A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer (ABIMMUNE)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

vaginal squamous tumor

vulva squamous cell carcinoma

anal squamous cell carcinoma

esophagus squamous cell carcinoma

lung squamous cell carcinoma

Therapies

Durvalumab + Tremelimumab

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.